Markets:

Overview

News

Currencies

International

Treasuries

Cencora, Inc. Common Stock (NY:COR)

341.50 +5.33 (+1.59%)

Delayed Quote Updated: 3:56 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

3 Market-Beating Stocks to Target This Week

March 20, 2025

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...

Via StockStory

What Analysts Are Saying About Cencora Stock ↗

March 14, 2025

Via Benzinga

Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

March 13, 2025

Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.

Via StockStory

Which S&P500 stocks are moving on Monday? ↗

March 10, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today ↗

February 14, 2025

Via Benzinga

Earnings Scheduled For February 5, 2025 ↗

February 05, 2025

Via Benzinga

$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗

January 29, 2025

Via Benzinga

Breaking Down Cencora: 6 Analysts Share Their Views ↗

January 24, 2025

Via Benzinga

Q4 Earnings Highlights: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks

March 04, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSE:UNH) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

2 Large-Cap Stocks with Exciting Potential and 1 to Avoid

March 03, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Topics Intellectual Property

Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best

March 03, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

What To Expect From Alignment Healthcare’s (ALHC) Q4 Earnings

February 26, 2025

Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be reporting earnings tomorrow after market hours. Here’s what to look for.

Via StockStory

Looking Into Cencora's Recent Short Interest ↗

January 02, 2025

Via Benzinga

What To Expect From Progyny’s (PGNY) Q4 Earnings

February 26, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results tomorrow after market close. Here’s what investors should know.

Via StockStory

What To Expect From Clover Health’s (CLOV) Q4 Earnings

February 26, 2025

Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for.

Via StockStory

1 Healthcare Stock to Hold Forever and 2 to Ignore

February 21, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

The Ultimate Guide To Stock Investing Success ↗

February 13, 2025

A discussion about how you can really identify stocks that you can add to your portfolio that will be winners in the long run.

Via Talk Markets

Topics Stocks / Equities

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 11, 2025

Via Benzinga

Humana Earnings On Deck: Investors Brace For Slower Growth Clip ↗

February 10, 2025

Humana to release Q4 2024 earnings on Feb. 11 before market hours. Previous quarter saw 15.2% revenue increase, EPS beat but missed guidance.

Via Benzinga

Humana (HUM) Q4 Earnings: What To Expect

February 10, 2025

Health insurance company Humana (NYSE:HUM) will be reporting results tomorrow before market hours. Here’s what to expect.

Via StockStory

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

February 07, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.

Via Chartmill

Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move ↗

February 07, 2025

Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an...

Via Benzinga

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

February 06, 2025

From Cencora

Via Business Wire

Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday? ↗

February 05, 2025

Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.

Via Benzinga

Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines ↗

February 05, 2025

Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and FY25 guidance was raised.

Via Benzinga

Cencora (NYSE:COR) Reports Upbeat Q4

February 05, 2025

Healthcare distributor Cencora (NYSE:COR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 12.8% year on year to $81.49 billion. Its non-GAAP profit of $3.73 per...

Via StockStory

Cencora Reports Fiscal 2025 First Quarter Results

February 05, 2025

From Cencora

Via Business Wire

Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower ↗

January 08, 2025

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Via Benzinga

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

January 08, 2025

From Cencora

Via Business Wire

Cencora Completes Acquisition of Retina Consultants of America

January 02, 2025

From Cencora

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.